secwatch.observer — SEC 8-K summary
======================================

Issuer:     QHSLab, Inc. (USAQ)
CIK:        0000856984
Form:       8-K
Filed at:   2023-10-18T23:59:59+00:00
Accession:  0001493152-23-037562
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QHSLab reports 30K+ digital assessments YTD, over $1M revenue for 9 months
--------------------------------------------------------------------------

- Over 30,000 patient digital medicine assessments in first 9 months of 2023; 800 initiated allergen immunotherapy.
- Unaudited revenue for nine months ended Sep 30, 2023 exceeded $1 million with growing gross margins.
- Physician client reimbursements increased 20-30% from adopting QHSLab digital health services.
- ISP service line forecast to double daily output by year-end 2023; 2024 assessment run rate expected >65,000.
- Platform added multi-language support, EHR matching, and automated patient self-management tools.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856984/000149315223037562/0001493152-23-037562-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856984/000149315223037562/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-037562

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer